Decision: Favourable

Study Title:

A MULTICENTER, OPEN-LABEL PHASE IV STUDY TO EVALUATE OVERALL HEALTH, PHYSICAL ACTIVITY, AND JOINT OUTCOMES, IN PARTICIPANTS AGED ≥ 13 AND < 70 YEARS WITH SEVERE OR MODERATE HEMOPHILIA A WITHOUT FVIII INHIBITORS ON EMICIZUMAB

  • NREC Code:

    22-NREC-CT-019

  • Decision:

    Favourable

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Beatrice Nolan

  • PI Institution:

    Children's Health Ireland

  • Sponsor:

    Children's Health Ireland

Scroll to Top
Skip to content